Press Releases

BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of senior management will participate in the following investor conferences: Stifel 2018 Healthcare Conference (November 13, New York): Fireside chat with Eric B

SANTA ANA, Calif.--(BUSINESS WIRE)-- Iteris, Inc. (NASDAQ: ITI), the global leader in applied informatics for transportation and agriculture, has been invited to participate at the

KIRKLAND, Wash.--(BUSINESS WIRE)-- Cardiac Insight, Inc., a leading U.S. developer of wearable cardiac biosensors and clinical diagnostic software systems featuring proprietary automated data analysis algorithms, announced today it has partnered with VivoSense®, a leader in integration and specialized analysis of wearable sensor data for research and clinical trials. Together, both companies will deliv

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Zingbox, the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform and leader of healthcare IoT securit

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular (CV) outcomes trial (CVOT) DECLARE (Dapagliflozin Effect on Cardiovascular Events)-TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company’s Cardiovascular, Renal & Metabolism (CVMD) th

CINCINNATI--(BUSINESS WIRE)-- Will an influx in new smartphones prompt professional marketers to take product photography into their own hands? Experts at Ocusell, developers of proprietary technology to create, enhance and share professional photos instantly, say it’s already happening. The firm holds a patent on a fusion algorithm that allows a cell phone to create High Dynamic Range (HDR) panoramas wit

WASHINGTON--(BUSINESS WIRE)-- Applied Insight, a market leader in solving complex technology challenges for federal government customers, announced today that it has

LISLE, Ill.--(BUSINESS WIRE)-- Molex, a leading global manufacturer of electronic solutions

EWING, N.J.--(BUSINESS WIRE)-- Church & Dwight Co., Inc. (NYSE:CHD):            

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its third quarter 2018 financial results after the close of market on Thursday, November 8, 2018. Tricida will host a conference call and webcast at 5:00 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows:

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced its financial results for the three and nine months ended September 30, 2018. Highlights of and subsequent to the third quarter of 2018 include: Business and Recent Highlights: Commenced a $50.0 mi

OSHKOSH, Wis.--(BUSINESS WIRE)-- Oshkosh Corporation (NYSE: OSK) today reported fiscal 2018 fourth quarter net income of $151.3 million, or $2.05 per diluted share, compared to $93.5 million, or $1.23 per diluted share, in the fourth quarter of fiscal 2017. Results for the fourth quarter of fiscal 2018 included after-tax charges and inefficiencies of $2.4 million associated with restruc

MONTREAL--(BUSINESS WIRE)-- SemaThera Inc., announces today that its board of directors has appointed Garth Cumberlidge as President and Chief Executive Officer. Dr. Cumberlidge was also elected to the board of directors of SemaThera. He will lead the company’s development programs in diabetic macular edema and other degenerative retinopathies. Its lead compound, ST-102, is a bispecific recombinant protei

CAMARILLO, Calif.--(BUSINESS WIRE)-- Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algori

MILWAUKEE--(BUSINESS WIRE)-- Gardner Denver Holdings, Inc. (NYSE: GDI) (“Gardner Denver”) today announced the pricing of the previously announced underwritten secondary offering by investment funds affiliated with Kohlberg Kravis Roberts & Co. L.P. (the “Selling Stockholder”) of 20,000,000 shares of common stock of Gardner Denver pursuant to a registration statement filed by Gardner